Lenvat 4 mg
Lenvatinib
Lenvat 4mg is used to treat advanced thyroid cancer. It slows cancer growth by blocking proteins that support tumour development and spread in the body.
- Strengths 4 mg
- Form Capsule
- Packaging Size 30 Capsules
- Packaging Type Box
- Manufacturer Natco Pharma Ltd
Description of Lenvat 4 mg
Lenvat 4mg is an anti-cancer medication used for the treatment of advanced thyroid cancer and other specific types of tumours. It contains Lenvatinib, a kinase inhibitor that works by blocking proteins responsible for cancer cell growth and spread. By targeting these proteins, lenvat helps slow disease progression and may reduce tumour size. It is usually prescribed when the cancer cannot be surgically removed or has spread to other parts of the body. Lenvat 4mg is taken orally under strict medical supervision. Regular monitoring is necessary during treatment to manage potential side effects and evaluate response.
Ingredients of Lenvat 4 mg
- Lenvatinib Mesylate – Equivalent to Lenvatinib 4mg (Active Ingredient)
- Pharmaceutical excipients (Inactive)
Usage of Lenvat 4 mg
- Taken orally once daily, with or without food.
- Dosage is based on patient weight, condition, and tolerance.
- Swallow the capsule whole with water—do not crush or chew.
- Should be taken at the same time each day.
- Regular follow-ups and blood tests are necessary.
Precautions for Lenvat 4 mg
- Inform your doctor about liver, kidney, or heart conditions.
- Not recommended during pregnancy or breastfeeding.
- May cause high blood pressure, fatigue, or loss of appetite.
- Use with caution in elderly patients or those with bleeding risk.
- Do not stop or change dosage without consulting your doctor.
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.
